Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.280
-0.200 (-5.75%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $270.82 million as of July 16, 2026. Its market cap has increased by 312.66% in one year.
Market Cap
270.82M
Enterprise Value
212.05M
1-Year Change
312.66%
Ranking
Category
Stock Price
$3.28
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $270.82M, an increase of 1,173.68%. That is a compound annual growth rate of 56.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 270.82M | 95.37% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 302.01M |
| OmniAb | 301.54M |
| Conexeu Sciences | 299.16M |
| InflaRx | 295.32M |
| Bicycle Therapeutics | 294.60M |
| Greenwich LifeSciences | 286.81M |
| Turn Therapeutics | 285.37M |
| Niagen Bioscience | 276.95M |